BACKGROUND: The prevalence of obesity is increasing worldwide, with a corresponding increase in overweight and obese patients referred with infertility. This systematic review aimed to determine whether non-surgical weight reduction strategies result in an improvement in reproductive parameters affected by obesity, e.g. delayed time to pregnancy, oligozoospermia and azoospermia. No prior reviews have examined this within the general fertility population, or in both sexes.
Introduction
Overweight is defined by the World Health Organization (WHO) (World Health Organization, 2016) as a BMI ≥ 25 kg/m 2 , and obesity as ≥ 30 kg/m 2 . The prevalence of obesity is increasing worldwide (World Health Organization, 2016) , with more than 600 million obese adults, including 15% of women, in 2014-double the prevalence reported three decades earlier. Infertility is defined by the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected sexual intercourse (Zegers-Hochschild et al., 2009; National Institute for Health and Clinical Excellence, 2013) . Using this definition, infertility affects~1 in 7 couples in the UK, which is similar to an estimate of prevalence in the USA (Thoma et al., 2013 ). An increasingly overweight and obese population has led to a greater proportion of individuals with high BMI being evaluated in infertility settings (Vahratian and Smith, 2009) . BMI has been associated with delayed conception in women in a dose-dependent fashion (Gesink Law et al., 2007; Wise et al., 2010 Wise et al., , 2013 . It is thought to produce anovulation (Zain and Norman, 2008; Klenov and Jungheim, 2014) , which results in menstrual irregularity (Hartz et al., 1979; Zain and Norman, 2008) ; impairment of oocyte development (Klenov and Jungheim, 2014) and quality (Carrell et al., 2001; Metwally et al., 2007) ; and it also has direct effects on the endometrium (Bellver et al., 2011) . With ovulation induction (OI) treatment, higher doses of medications (Dickey et al., 1997; Balen et al., 2006a) and a longer period of stimulation (Balen et al., 2006b) are required with a higher BMI. With IVF, the chances of achieving a pregnancy decrease with each unit increase in BMI (Ferlitsch et al., 2004) , and it is thought that implantation rates are lower in obese women (Styne-Gross et al., 2005; Bellver et al., 2010 ). An increased risk of miscarriage following IVF has also been reported (Maheshwari et al., 2007) .
Obesity may affect male fertility in a dose-dependent manner (Sallmen et al., 2006) . Postulated mechanisms include increased testicular temperature with prolonged sitting (Hammoud et al., 2012) , and increased oestrogen production in fat with disruption of the hypothalamo-pituitary-gonadal axis (Schneider et al., 1979; Shukla et al., 2014) . Some studies have suggested that reduced sperm concentration and motility (Hakonsen et al., 2011; Hammiche et al., 2012; Sermondade et al., 2013) , and lower clinical pregnancy rates with IVF (Keltz et al., 2010; Umul et al., 2015) with increasing male adiposity. Where both partners are obese, greater difficulty achieving pregnancy is expected (Ramlau-Hansen et al., 2007) .
Patients attending for fertility treatments are often advised to optimize their weights to improve outcomes, and in some cases to access assistance with funding (Farquhar and Gillett, 2006 ; National Institute for Health and Clinical Excellence, 2013; Infertility Network UK, 2015) or to reduce the risks of obstetric complications (The Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2011) .
The purpose of this systematic review was to investigate first whether weight-loss interventions for infertile patients achieve their goal in reducing weight, and second whether they result in improved fertility outcomes. A prior systematic review of 11 studies in women (Sim et al., 2014b) focussed on assisted reproduction only and used a much more limited search for studies up until 2014. Our review used an extensive search until 2016 and presents data from 40 studies with women and men with infertility, not just patients requiring assisted reproduction.
Methods
This systematic review was undertaken according to a pre-specified protocol.
Criteria for considering studies for this review

Types of studies
We included intervention studies in overweight or obese participants with any design and any duration of follow-up.
Types of participants
Participants could be of either sex. They were required to have both infertility, defined by an unfulfilled desire to conceive of any duration or attendance for infertility investigations or treatment, and a prescribed period of attempt at weight loss. A BMI ≥ 25 kg/m 2 was used to define overweight, and ≥30 kg/m 2 to define obesity (World Health Organization, 2016) ; participants were required to be at least overweight. Morbid obesity was defined by BMI ≥ 40 kg/m 2 . Studies were excluded if participants were not actively attempting pregnancy, or had an illness or eating disorder that might result in weight fluctuation.
Types of interventions
Any intervention for weight loss allowed inclusion, for example prompt for weight reduction, dietary modification, exercise, psychological or behavioural counselling, or the drug orlistat. Bariatric surgery was not included. Alternative or control interventions were included where evaluated in included studies.
Types of outcome measures
Primary outcomes were weight change, achievement of pregnancy and live birth, the latter defined as the complete expulsion or extraction from its mother of a product of fertilization, which, after such separation, breathes or shows any other evidence of life such as heart beat, umbilical cord pulsation or definite movement of voluntary muscles, irrespective of whether the umbilical cord has been cut or the placenta is attached (National Institute for Health and Clinical Excellence, 2013) . Secondary outcomes were BMI change; waist circumference change (North American Association for the Study of Obesity et al., 2000) ; miscarriage, defined as a loss of pregnancy before 23 + 6 weeks of gestation (Anonymous, 2012) ; ovulation improvement, with anovulation defined by suboptimal rise in LH or a below-threshold serum progesterone level taken in the mid-luteal phase of the menstrual cycle (National Institute for Health and Clinical Excellence, 2013) ; improvement in menstrual regularity, with irregular cycles defined as outside the range of 26-36 days (National Institute for Health and Clinical Excellence, 2013) ; and time to conception (TTC).
Search methods for identification of studies
The dates searched were 1 January 1966-19 March 2016. No restriction was placed on language of origin, and studies could be included regardless of whether they had been published. The electronic databases used were MEDLINE, EMBASE and the Cochrane Library. Additional studies were identified through review of the references of the retrieved papers, contact with study authors, and online searching of Google and Google Scholar (Google Inc., Mountain View, CA, USA). The search strategy used for MEDLINE and EMBASE is given in the Supplementary Data.
Data collection and analysis
Selection of studies
The titles and abstracts obtained were screened by one author (D.B.). To verify the process of selection, the titles and abstracts for the year 2000 were independently screened by D.B. and A.A., with full agreement with respect to papers to be included or excluded. Thus, full text versions of all relevant papers were retrieved by D.B. for further scrutiny by both reviewers. Any disagreement between the two as to which studies to include was resolved by discussion.
Data collection process
Data were extracted by one reviewer (D.B.), and checked by a second (A.A.). Discrepancies were resolved by discussion between the reviewers, and a third reviewer (S.B.) was available for referral as necessary. Study authors were contacted as required for missing data or clarification.
For each included study, the information collected included study design; methods; location, setting and time period; information about the participants (demographics, infertility diagnosis, BMI, eligibility criteria); drop-outs; the types of interventions assessed and their descriptions; and outcomes, including pregnancy, live births, weight or BMI change, miscarriage, ovulation and menstrual change. For men, semen analysis parameters were captured. Any data on barriers to weight loss were also captured. Data on costs and cost-effectiveness were sought but not found.
Assessment of risk of bias in individual studies
Randomised control trials (RCTs) were assessed for their methodological quality using the Cochrane Risk of Bias Tool (Higgins et al., 2011) .
Non-randomized studies were assessed using a checklist developed for the Review Body for Interventional Procedures (ReBIP). The ReBIP is an independent review body that carries out systematic reviews for the National Institute for Health and Care Excellence's Interventional Procedures Programme. The checklist was adapted from several sources (Verhagen et al., 1998; Downs and Black, 1998; Khan et al., 2001) , and has been used in many systematic reviews. It includes assessment of sample selection; clarity of inclusion and exclusion criteria; baseline comparability of participants; consecutive selection of patients; prospective data collection; clarity of intervention descriptions; experience of person administering the intervention; appropriateness of staff, place and facilities where participants were treated; consideration of important incomes on clinical effectiveness, cost-effectiveness or learning curves; the use of objective outcome measures; blinding of outcome assessment; adequacy of duration of follow-up to detect important effects on outcomes of interest; information provision on drop-outs, and their similarity to completers; identification of important prognostic factors; and adjustment of analyses for confounding factors.
Summary measures
Results were summarized descriptively. In the outcome summary tables, numbered rankings are provided in an effort to demonstrate which study interventions reported more favourable outcomes, with a lower number indicating a better outcome. Meta-analysis was undertaken where possible. Risk ratios (RR) and mean differences with 95% CI between groups are reported.
Synthesis of results
Data were imported into Review Manager Version 5.3.5 (The Cochrane Collaboration, Oxford, UK) for quantitative synthesis. A random effects, rather than a fixed effect model, was used for meta-analysis, owing to unavoidable population and intervention heterogeneity, as anticipated in interventions for weight loss.
Assessment of heterogeneity
Statistical heterogeneity was investigated by visual inspection of forest plots, the Q-test (with P < 0.1 implying statistical heterogeneity) and by examining the I 2 statistic (Higgins and Thompson, 2002) , where a result >50% was taken to indicate substantial statistical heterogeneity.
Sensitivity analyses
Sensitivity analysis was planned to compare randomized trials judged to be at low risk of bias for allocation concealment or randomization with those judged to be at higher risk of bias; however, the small numbers of trials precluded this.
Results
Outcome of the search
Details of the selection process for studies is summarized in the PRISMA flow diagram (Fig. 1) . Seventeen study authors were contacted for clarification or further information; ten provided helpful further information.
Full details of all the studies and interventions are provided in Supplementary Table SI. There were 14 RCTs, 6 non-randomized studies with comparison groups (NRCTs) and 20 cohort studies with interventions. Ten studies took place in Australia, seven in the USA, three each in Italy and the Netherlands, and two in Denmark. One each came from Belgium, Brazil, Canada, Egypt, France, Germany, India, Iran, Jordan, Pakistan, Russia, Saudi Arabia, Slovakia, Turkey and the UK. Three studies were multi-centre.
Enrolment varied from 8 participants (Faure et al., 2014) to 577 (Mutsaerts et al., 2016) . Attrition rates ranged from 10.6% (Mutsaerts et al., 2016) to 66.7% (Turner-McGrievy et al., 2014) .
Description of populations
Mean age of study groups varied from 25 years (Lazurova et al., 2004) to 35.4 years (Chavarro et al., 2012) . Ethnicity was reported in six papers, with between 55% (Turner-McGrievy et al., 2014) and 87.5% white (Mutsaerts et al., 2016) .
Duration of infertility, where reported, ranged from a mean of 19.5 months (Palomba et al., 2008) to 11 years (Aliyeva et al., 1993) . Some studies addressed women with any infertility history. Others centred on women undergoing fertility treatments or planning to start immediately following the intervention. Some were exclusively catered to persons with polycystic ovary syndrome (PCOS), with the syndrome defined by Rotterdam 2004 consensus criteria (ESHRE and Group, ASRM-Sponsored PCOS Consensus Workshop, 2004) in ten cases, National Institutes of Health criteria (Zawadzki and Dunaif, 1992) in one case, ultrasound appearance of the ovaries in two cases, and not specified in five cases. One study used PCOS as an exclusion criterion (Moran et al., 2003) . In eight studies, patients were anovulatory, and in seven studies patients had irregular menstrual cycles. Three papers were centred on patients who were resistant to clomiphene citrate for OI.
The lowest mean BMI was 24.5 kg/m 2 (Chavarro et al., 2012) , and the highest was 44 kg/m 2 (Hakonsen et al., 2011; Mahoney, 2014) .
Two studies were centred on men. One had participants with sperm DNA fragmentation who were overweight or obese (Faure et al., 2014) , while the other examined obese men only (Hakonsen et al., 2011) . One study examined a weight-loss intervention in couples (Homan et al., 2012) . Table I provides brief details of the types of interventions tested. In general, interventions were poorly described, with insufficient detail to allow their replication. Where described, most reducing diets followed healthy eating principles by reducing fat and refined carbohydrate intake. Where available, studies described calorie intakes ranging from 1000 to 2000 kcal/d (depending on body size), apart from three studies that tested very low calorie diets as part of their reducing diets (Tsagareli et al., 2006 , Kiddy et al., 1992 , van Dam et al., 2004 and one that tested a very low carbohydrate ketogenic diet (Mavropoulos et al., 2005) . If physical activity advice or programmes were incorporated into interventions, they were generally for aerobic exercise. There was no clear evidence that any particular regime was more effective for weight loss, providing there was a weight reduction diet prescribed.
Description of interventions
Five of the sixteen interventions incorporating both a dietary and physical activity component provided some part of the intervention in a group setting. Only two interventions were described involving couples. One study (Chavarro et al., 2012) tracked participants' weights after administering a lifestyle questionnaire. While this is not strictly a weight-loss intervention, we have included it with the other cohort studies, because there is evidence that weight loss occurs with enrolment in studies tracking weight, even with minimal intervention (Waters et al., 2012; Johns et al., 2016) .
Quality of studies
The quality of the studies included was variable. For full details of risk of bias assessment for the randomized studies please see Supplementary Table SII. Three of fourteen RCTs had four or five out of seven domains with low risk of bias, e.g. allocation concealment, incomplete outcome data, but the Lifestyle trial (Mutsaerts et al., 2016) stood out as the one with best quality. All studies were of high risk of bias with respect to blinding of participants to treatment allocation, and all had low risk of bias in at least two domains. Five of twenty-six non-randomized studies, having eight to nine of fourteen domains with low risk of bias, were judged to be good quality. Full details of the risk of bias assessment for the non-randomized studies are given in Supplementary Table SIII .
Studies involving female infertility participants Pregnancy
Aggregated data from six RCTs show that women who received a combination of a reducing diet and exercise had higher pregnancy rates than those who underwent standard care, 238/434 (54.8%) versus 221/443 (49.9%); RR 1.59, 95% CI (1.01, 2.50) (Fig. 2) . The trial by Mutsaerts et al. (2016) contributed significantly to the heterogeneity, I 2 = 71% and its exclusion in a post hoc sensitivity analysis reduced
Although the numbers of participants in other RCTs were too few for any meaningful conclusions to be drawn, a very small trial was unable to demonstrate any advantage of diet alone, while another suggested that orlistat might be beneficial. The results of an NRCT (Clark et al., 1998) support the result of the meta-analysis favouring diet and exercise. The study by Koning (2015) did not show any advantage associated with motivational interviewing.
Table II details the reproductive outcomes for all included studies. Diet and exercise studies without control populations achieved rates that were comparable to those included in the meta-analysis.
Live births
Data from five RCTs ( Women in studies on diet and exercise without control groups had lower success rates than those included in the meta-analysis. Khaskheli et al., (2013) , who did not provide details of their intervention, reported a 37.6% (32/85) live birth rate, while Crosignani et al., (2003) , who administered a 1200 kcal/day diet along with aerobic exercise, achieved a 24.2% (8/33) rate. The numbers of participants in the other studies included in Table II were too few for any meaningful conclusions to be drawn. (Table II) .
Natural and IVF conceptions
Ovulation
One RCT (Palomba et al., 2010) found a 37.5% (12/32) ovulation improvement with a combination of reducing diet and exercise, while its control group had a 9.3% (3/32) improvement rate; RR 4.00 95% CI (1.25, 12.84) (Fig. 8 ). An NRCT, also using diet and exercise, had the highest rate of improvement of all included studies in its intervention group, 89.6% (60/67), while none of the participants in the control group saw improvement; RR 37.37, 95% CI (2.41, 578.65).
One RCT (Kumar and Arora, 2014) compared the use of 120 mg of orlistat twice daily and a lifestyle modification programme with use of the lifestyle programme alone. The orlistat group had a 50% (15/ 30) rate of ovulation, while the control group had a 6.7% (2/30) rate; RR 7.50, 95% CI (1.88, 29.99).
One RCT (Legro et al., 2015) compared the proportions of total clomiphene treatment cycles that were ovulatory in each group. The group whose treatment was preceded by diet and exercise advice and the oral conceptive pill (OCP) had the best ovulation rate, 67.1% (94/ 140), while the lifestyle alone group and control (OCP alone) group had rates of 60.3% (82/136) and 46.1% (71/154), respectively.
Another RCT (Thomson et al., 2008) randomized its participants, who had PCOS, to receive an energy-restricted high-protein diet alone (DO), combined with aerobic exercise (DA) or combined with both aerobic and resistance exercise (DC 12) improvement in ovulation, DA a 50% (3/6) improvement, and DC a 42.8% (3/7) improvement. Table II shows the ovulation rates in cohort studies of diet without controls. One study using a very low calorie diet (van Dam et al., 2004) had a relatively good ovulation improvement rate, 60% (9/15). Other studies had comparatively low rates, including one using a hypocaloric 1434 kcal/day diet (Thomson et al., 2009 ) which achieved a 19.2% (10/52) rate, and another (Turner-McGrievy et al., 2014) which saw no improvement using either a low calorie diet or a vegan diet. One study compared a hypocaloric high-protein diet to structured exercise training (Palomba et al., 2008) , and achieved a 25% (5/20) improvement rate with diet, and a 65% (13/20) improvement with exercise.
A study comparing ovulation improvement in women receiving acupuncture to those receiving an unspecified diet (Aliyeva et al., 1993) had a 55% (11/20) improvement with the former, and 46.7% (28/60) improvement in the latter; RR 1.18, 95% CI (0.73, 1.90). 
Menstrual irregularity
In clomiphene citrate resistant PCOS women, a single trial (Palomba et al., 2010) , showed that hypocaloric diet and exercise was significantly more likely to result in menstrual improvement, than observation only: 34.4% (11/32) versus 9.3% (3/32); RR 3.67, 95% CI (1.13, 11.92) (Fig. 9) . Other studies without control groups also suggest that diet and exercise were associated with improvement in menstrual regularity (Table II) . There were no RCTs evaluating the role of dietary interventions alone or motivational interviewing in regulating menstrual cyclicity. Data from observational and often uncontrolled studies of other interventions show variable levels of success (Table II) .
Oocyte retrieval
Data from a single RCT (Fig. 10) suggest that a low-glycaemic index diet (Becker et al., 2015) could improve oocyte yield in IVF. The mean (SD) number of oocytes in women in the intervention arm was 7.75 (5.39), compared to 4.18 (SD 3.01) in controls; mean difference −3.57, 95% CI (−6.87, −0.27).
Time to conception
The Lifestyle trial (Mutsaerts et al., 2016) reported that the median TTC resulting in a term live birth was 7.2 months (interquartile range (IQR) 2.6, 12.0) in the intervention group, who underwent a multidisciplinary programme based on diet and exercise, versus 5.2 (IQR 2.4, 10.1) in the control group, who were allowed fertility treatment from the start (P = 0.06). An RCT comparing energy-restricted low-and high-protein diet groups who both received exercise instruction (Moran et al., 2003) reported a 4-5 week TTC regardless of group. A cohort study which advised women to lose 10% of their body weight (Kort et al., 2013 (Kort et al., , 2014 found that those who met the target had a mean TTC of 227 days, while those who had not had a mean of 231 days.
Weight loss
Aggregated data from RCTs suggest that a combination of a reducing diet and exercise resulted in greater weight loss than that achieved in control groups (Fig. 11) ; mean difference -3.98 kg (95% CI −4.85, −3.12). Diet alone was also shown to be more effective in a small RCT; mean difference −5.23 kg (95% CI −7.42, −3.04) (Becker et al., 2015) .
In non-randomized trials, Clark et al. (1998) reported that significantly greater weight loss from diet and exercise; mean difference −9.00 kg (95% CI −10.88, −7.12). Two non-randomized trials testing motivational interviewing also found greater weight loss; mean difference −3.21 kg (95% CI −5.93, −0.49 kg). Changes in weight, BMI and waist circumference for other studies are provided in Table III . Generally results are not inconsistent with studies with either randomized or non-randomized control groups.
Comparisons with metformin Pregnancy
Three small RCTs evaluated lifestyle interventions versus metformin (Fig. 12) . None was able to show any superiority of metformin over the alternative intervention, but it is difficult to be confident about these outcomes owing to the small sample sizes involved.
Ovulation
Two small RCT of diet or drug treatment (Fig. 13) were unable to show any benefit over metformin. Details of other studies are in Table II .
Menstrual irregularity
Metformin did not appear to improve menstrual regularity in a number of small trials comparing it to diet and exercise with or without drug treatment, diet alone or acarbose (Fig. 14) . Details of other studies are in Table II . 
Weight loss
Weight, BMI and waist circumference changes for studies comparing metformin with lifestyle interventions are provided in Table III .
Summary of the key findings in infertile women
In overweight and obese infertile women, weight loss is associated with improved chances of becoming pregnant, and possibly natural conception pre-IVF. Ovulation and menstrual irregularity are also aided. There appears to be no significant difference between weight-loss interventions and controls with respect to rates of miscarriage and IVF conceptions. The few studies that included metformin showed no significant difference between weight-loss interventions and the drug for achieving pregnancy or improvement in ovulation status; similarly there was no difference between the two groups in menstrual improvement.
Barriers to weight loss in infertile women
Very little has been reported regarding the perceived barriers to weight loss in overweight and obese infertile women. Two of the included studies attempted in some way to evaluate these.
In the trial by Thomson et al. (2008) , 104 participants were allocated to receive an energy-restricted diet only (DO), the same diet combined with five sessions of aerobic walking and jogging exercise per week (DA), or the diet combined with aerobic and resistance training exercises (DC), where resistance exercise replaced two of the aerobic sessions. Forty-three of the participants in the trial (DO = 13, DA = 11 and DC = 19) completed a validated Exercise Benefits/Barriers Scale at weeks 0, 10 and 20 (Thomson et al., 2016) . This was to determine their perceptions of the benefits and barriers to participation in exercise. The scale included 43 items with statements related to ideas about exercise and a four-point Likert scale, with 4 = strongly agree, 3 = agree, 2 = disagree and 1 = strongly disagree. At baseline, the statements with the highest agreement were 'exercise tires me ' [mean (SD) Barrier scores were reduced by week 10 in this study, regardless of treatment allocation, with no further reduction by week 20 (P ≤ 0. 001). Time expenditure and physical exertion as perceived barriers saw a significant reduction (P ≤ 0.003), while family discouragement saw no change (P = 0.6).
Participants in the study by Galletly et al. (1996a) , in addition to completing a 24-week programme with weekly meetings comprising 1 h of exercise and 1 h of dietary and psychiatric counselling, completed the Rosenberg Self-Esteem Scale and the General Hospital Anxiety and Depression Scale at the start and end of the study. At baseline, those who dropped out before the end of intervention exhibited higher anxiety (P < 0.02) and depression scores (P < 0.069), and lower self-esteem scores (P < 0.056) than those who completed. Completion was associated with a significant improvement in self-esteem (P < 0.0001) and depression (P < 0.006), and a non-significant reduction in anxiety scores. 
Vegan diet 9 28 −2.1 ± 3.5
Turner-McGrievy et al. 
Continued
Based on what little evidence is available, overweight infertile women appear most deterred from exercise by the perception that it causes fatigue and is hard work. These perceptions, as well as depression, seem to decrease with continuation of an exercise programme. Very few women seem to be discouraged from exercise by family members. Those women who discontinue exercise would appear to be more anxious and/or depressed at the outset.
Studies involving male infertility participants
Achievement of pregnancy, live birth rate and Improvement in sperm DNA integrity One cohort study (Faure et al., 2014 ) administered a nutritionist-led personalized dietary programme of an unreported nature coupled with exercise, aimed at reducing intra-abdominal fat over a 3-8 month period, to eight men who had significant abdominal fat and at least 25% sperm DNA fragmentation and unexplained infertility (Table IV) . The partners of all eight achieved pregnancy, three naturally and five through IUI, and all went on to have live births. Six who allowed their semen samples to be analysed both before and after the intervention all had an improvement in the degree of sperm DNA fragmentation.
Improvement in semen analysis parameters
A cohort of 44 men with BMI 33-61 kg/m 2 underwent a programme based on a healthy diet and daily exercise (Hakonsen et al., 2011) . Semen analyses before and afterward were compared in 27 men, and the results were as shown in Table IV .
Change in weight
Table IV also summarizes the weight loss achieved in both studies.
Summary
The relative paucity of studies in overweight and obese men seeking fertility has made it difficult to draw firm conclusions regarding the benefits of weight loss. However, improvements in sperm concentrations, motility and normal morphology have been suggested, though these have not been statistically significant. Improvement in sperm DNA integrity has also been suggested, and this might be linked to an improved live birth rate.
Discussion
Key findings
The present systematic review and meta-analysis found that the weight-loss interventions, particularly diet and exercise, improved pregnancy rates and ovulatory status. A trend toward more natural pregnancies, but not IVF pregnancies, occurred. Miscarriage rates were unaffected by weight-loss interventions and, as reports of higher oocyte yield and improved menstrual regularity are based on single trials, further research is needed before firm conclusions can be made. A lack of RCTs in men and couples, and of studies evaluating barriers to undertaking weight loss in overweight and obese infertile populations, is evident. The quality of the studies we included was variable, but the one with the lowest risk of bias was the Lifestyle trial (Mutsaerts et al., 2016) , whose intervention also ranked highly for both pregnancy and live birth rates. 
Women
Pregnancies and live births
Weight loss interventions, particularly those with reducing diets and exercise, were more likely than controls to result in pregnancy. Live births were reported by relatively fewer studies, usually involving women undergoing fertility treatments such as OI or IVF. Data from studies predating the Lifestyle trial in 2016 (Mutsaerts et al., 2016) suggested that diet and exercise combinations were superior to standard care, but inclusion of this trial changed this. Those in the intervention arm underwent a 6-month programme based on diet and exercise, prior to undergoing 18 months of fertility treatments. Those in the control arm commenced fertility treatments immediately. The primary outcome was vaginal birth of a healthy singleton of at least 37 weeks' gestation within 24 months after randomization. The trial was well conducted, with low risk of bias. This was the largest study in the review, and it carried substantial weight during meta-analysis. The results deviated from the trend exhibited by the preceding trials, resulting in marked increase in heterogeneity. It is possible that the results might have been different if the control group underwent 6 months of no intervention observation prior to 18 months of treatment. The trial found that significantly more women in the intervention group had ongoing pregnancies from natural conception than the control group, consistent with our other findings. Studies reporting the highest pregnancy and live birth rates were not necessarily those with highest weight loss. Clark et al., had a high live birth rate of 67.2% in the diet and exercise arm of their NRCT, while also achieving one of the highest weight changes, mean −10.2 kg (SD 4.3) (Clark et al., 1995 (Clark et al., , 1998 . On the other hand, the intervention arm of the Mutsaerts et al. (2016) RCT reported a live birth rate of 53.2%, but only achieved a mean weight change of −4.4 kg (SD 5.8).
Miscarriages
Studies with some of the lowest rates of weight loss reported fewer miscarriages in their intervention arms, but the data are insufficient to draw conclusions (Tables II and III) .
Ovulation
Weight-loss interventions, regardless of their nature, were significantly more likely than control interventions to achieve ovulation in anovulatory women. Improvements were not necessarily greatest in those studies achieving the greatest weight loss.
Menstrual irregularity
A single RCT suggested that diet and exercise were significantly more likely to improve menstrual cycles than a control intervention (Palomba et al., 2010) . High rates of menstrual improvement were seen in studies with good weight or BMI reduction. Qublan et al. (2007) , for example, with a 1200-1400 kcal diet in their RCT, had a 61.9% menstrual improvement and achieved one of the better BMI reductions, with a mean change of −4.8 kg/m 2 .
Natural and IVF conceptions
Studies included women expected to proceed to in vitro treatments after a period of weight loss. Many women were able to conceive without further assistance through weight loss alone. All interventions showed an improved rate of natural conception in comparison to a control. There was however no significant difference between interventions and controls when it came to IVF conceptions. Similar natural conception rates were seen regardless of type of intervention and/or amount of weight lost. 
Change in weight, BMI and waist circumference
No class of intervention was consistently better in achieving reduction in weight compared to others. Trials with longer interventions and follow-up sometimes suffered from higher rates of study drop-out, for example 20.4% in the 12-month Sim et al. RCT (Sim et al., 2014a) and 10.6% in the 6-month Mutsaerts et al. RCT (Mutsaerts et al., 2016) , both of which mainly had diet and exercise. Others had no drop-out: Karlsen et al. after 7-8 months (Karlsen et al., 2013 ) and Koning after 6 months (Koning, 2015) , and both included motivational interviewing. This suggests that enhancing motivation plays a key role in compliance. Programmes with strict dietary and exercise modifications may be more likely to see discontinuation. The study with the most weight lost, the cohort study by Mavropoulos et al. (2005) , utilized a very restrictive diet for 6 months, and had very low recruitment (n = 11) and a high rate of drop-out (58.5%).
Metformin
The meta-analyses showed that weight-loss interventions have a nonsignificant advantage over metformin with respect to achievement of pregnancy or improvement of ovulation status. There was also no significant difference in menstrual regularity improvement. In light of these findings, and the gastro-intestinal side-effects common with metformin (Qublan et al., 2007; Kumar and Arora, 2014) , lifestyle interventions should remain the first line therapy for improvement in ovulation and menstruation.
Interventions in infertile men
There was very little evidence available to judge the effectiveness of weight reduction strategies in men, and this is an area ripe for future research. The two studies both utilized a diet and exercise combination, with neither providing adequate details of the intervention. Change in sperm motility (% motile) Group 1 (n = 8) Mean −2 95% CI −15, 11 Group 2 (n = 9) Mean +4 95% CI −10, 18 Group 3 (n = 9) Mean +11 95% CI −3, 25
Change in normal sperm morphology (% normal forms) Group 1 (n = 9) Mean 0 95% CI −2, 4 Group 2 (n = 9) Mean +1 95% CI −3, 4 Group 3 (n = 9) Mean +4 95% CI 1, 7
Change in weight (kg) Mean −4.40 SD 5.00
Median −22 Range −4 to -39
Change in BMI (kg/m 2 ) Mean −1.22 SD 1.38
Change in Waist circumference (cm) Mean −8.50 SD 7.89
Types of diet
As expected, the dietary interventions used were based on caloric restriction, and were usually consistent with weight reduction advice from national guidelines (National Clinical Guideline Centre, 2014; Dietz et al., 2015) . It is hard to say, based on the data obtained, whether any particular degree of restriction was superior for achievement of weight loss, particularly given the frequent pairing of diet with exercise. Some of the RCTs used individualized diets, tailoring caloric deficit to baseline weight (Becker et al., 2015; Duval et al., 2015b) . Others mentioned a hypocaloric range within which dietary intakes would fall (Qublan et al., 2007; Thomson et al., 2008; Kumar and Arora, 2014; Turner-McGrievy et al., 2014) , generally between 1200 and 1800 kcal/day. Dieticians were used to assist with dietary advice in a few cases (Thomson et al., 2008; Turner-McGrievy et al., 2014; Duval et al., 2015b; Mutsaerts et al., 2016) . The RCT with the lowest recruitment and highest discontinuation rate used a vegan diet in one of its study arms (Turner-McGrievy et al., 2014) , suggesting poor acceptance.
Types of exercise
The majority of exercise interventions sought to increase weekly aerobic activity in participants in order to increase caloric expenditure.
The most frequent feature seen in the RCTs was an increase in the number of steps or amount of walking by participants (Thomson et al., 2008; Karimzadeh and Javedani, 2010; Sim et al., 2014a; Legro et al., 2015; Duval et al., 2015b; Mutsaerts et al., 2016) . Fewer RCTs included strength or resistance training (Thomson et al., 2008; Karimzadeh and Javedani, 2010; Moran et al., 2011b) , and this was always in addition to the basic aerobic approach. Thomson et al. found that addition of resistance training did not result in a significantly different weight loss in their RCT of diet alone, diet with aerobic exercise, or diet with aerobic and resistance exercise (Thomson et al., 2008) . Physical activity interventions were in some cases individualized (Moran et al., 2011a; Duval et al., 2015a) and in others in the form of group sessions (Moran et al., 2003) , with occasional use of a kinesiologist (Duval et al., 2015a) or physiotherapist (Kumar and Arora, 2014) .
Types of weight-loss medication
The use of weight loss drugs is contraindicated during pregnancy (Department of Veterans Affairs, 2014), and the studies using them aimed to reduce weight prior to attempting pregnancy. One trial (Legro et al., 2015) recommended barrier contraception during its intervention. Oral medications used in the studies included orlistat, a lipase inhibitor; sibutramine, a selective serotonin and norepinephrine reuptake inhibitor; and acarbose, an alpha-glucosidase inhibitor shown to induce modest weight loss, though not suitable for weight maintenance (Hauner et al., 2001) . Of these, sibutramine, which has been withdrawn in Europe and the USA but is still available on the internet, has been shown in a large study to have a risk of cardiovascular defects in unborn infants (Källén, 2014) , while the same study showed no risk of birth defects from orlistat use. The safety of acarbose in pregnancy is not established. Orlistat was shown to be superior to a control with respect to achievement of pregnancy and ovulation in a single study (Kumar and Arora, 2014) . Until further evidence is available, lifestyle interventions should still be considered the first line therapy, with drug use reserved for monitored trials.
Strengths and limitations of the review
This review has added to the scope of the systematic review by Sim et al. (2014b) by going beyond examining overweight and obese women undergoing fertility treatment to encompass individuals of both genders, and couples, from a variety of infertility circumstances undergoing non-surgical weight-loss programmes. A wide search strategy meant that we were thus able to capture 40 studies, in comparison to the 11 in that review (Sim et al., 2014b) . Author contact, initiated with 17 study authors, was another strength, as this allowed unreported information to be gained, and clarification of unclear information. Nevertheless, we cannot exclude publication bias, where studies with less positive outcomes remain unreported.
Clinical recommendations
Overweight and obese persons seeking fertility should be educated on the effects of being overweight or obese on the ability to achieve pregnancy, and the benefits of weight reduction, including improvement in pregnancy rates, and a reduced need for OI and IVF. A combination of a reduced calorie diet, which is not overly restrictive, and aerobic exercise, intensified gradually, should form the basis of programmes designed for such individuals. As compliance is key to success, coached sessions of achievable frequency, e.g. weekly, for up to 6 months, should be considered. Motivational interviewing techniques might also be useful. An advantage of fertility care is that couples are catered to, and dual enrolment may result in better adherence, as partners tend to motivate each other.
Research recommendations
Future research would ideally be in the form of large multi-centre RCTs including both women and men, ideally couples, attending fertility clinics and having at least one partner with a BMI within the overweight or obese range. Based on the data from RCTs of diet and exercise examined here, we estimate that a trial would require over 454 participants to detect a difference of 15% in pregnancy rates (90% power, P < 0.05, control pregnancy rate 50%, intervention rate 65%). This figure does not take account of losses to follow-up, and would need to be considerably inflated, depending on drop-out rates in feasibility and pilot work.
A reasonable control intervention would be the administration of dietary and exercise advice only, to be undertaken for a brief period to reduce persons allocated to this arm feeling as though their fertility treatments were being delayed with no intervention. Similar durations employed between intervention and control groups prior to starting fertility treatments would allow for fair comparisons with respect to weight loss and reproductive outcomes.
A long duration of follow-up, spanning decades, might answer further questions, including whether obstetric problems related to weight such as gestational diabetes or caesarean rates might be reduced in imminent or future pregnancies. The permanency of lifestyle changes made while attempting fertility might also be established, as well as their impact on family members, and the maintenance of weight loss in the long-term.
Conclusions
Non-surgical weight reduction strategies in the infertile have been shown to improve reproductive outcomes in both men and women. Diet, exercise, a combination of the two, weight-loss medication and motivational interviewing have all been efficacious in reducing obesity. In women, weight loss from diet and exercise is associated with improved chances of becoming pregnant, with a trend toward improved live birth rate. Ovulation and menstrual irregularity are also aided. At present there appears to be no significant difference between weight-loss interventions and control interventions with respect to rates of miscarriage and IVF conceptions. Well-designed RCTs should also shed light on the effect of weight loss on numbers of oocytes retrieved and other parameters in IVF cycles, and on TTC, as well as the role of interventions in couples. In men, improvements in sperm concentrations, motility and normal morphology have been suggested, as well as in sperm DNA integrity, but further high quality research is needed to confirm these findings and demonstrate improvement in live birth rates in their partners.
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